One of the main goals of Life4me+ — is to prevent new cases of HIV and other STIs, hepatitis C and tuberculosis.

The app helps to establish anonym communication between physicians and HIV-positive people. It allows you to conveniently organize your medication intake timetable and set concealed and personalized reminders.

All news

Archive

✕

27 sierpnia 2018

8720

Europe is close to achieving the goal of "90-90-90". But not all

Europe is close to achieving the goal of "90-90-90". But not all

According to a study published in the journal AIDS (JAIDS), Europe is close to achieving the goal of UNAIDS 90-90-90. According to the latest data, 81% of people living with HIV are aware of their status, 84% of them are receiving the necessary treatment, 88% of whom have ...

20 sierpnia 2018

11005

Former UN Secretary-General Kofi Annan died

Former UN Secretary-General Kofi Annan died

Former UN Secretary-General, Nobel Peace Prize winner Kofi Annan died at the age of 80. As Secretary General, he conducted UN reform, devoted a lot of time to the fight against HIV and implemented the UN Global Compact. In 2001, he made a proposal to create the Global Fund ...

18 sierpnia 2018

9514

Drug resistance to ARVT: new recommendations for testing and monitoring

Drug resistance to ARVT: new recommendations for testing and monitoring

Last month, a scientific journal on clinical infectious diseases published new recommendations of the International Antiviral Community (IAS) on testing and monitoring drug resistance to antiretroviral drugs used in HIV treatment.

16 sierpnia 2018

8371

Trogarzo affects the restoration of immunity

Trogarzo affects the restoration of immunity

The results of the 3 phase clinical trials of ibalizumab confirmed that the agent not only reduces the level of replication of drug-resistant strains of HIV, but also has a beneficial effect on restoration of immunity. According to scientists at Yale University, the use ...

15 sierpnia 2018

8322

GSK was told about the results of studies of prospective two-component ART

GSK was told about the results of studies of prospective two-component ART

#ViiV Healthcare, a division of the British pharmaceutical company GlaxoSmithKline, spoke about the promising results of studies of innovative therapy against HIV of cabotegravir / rilpivirin, which will reduce the intake of necessary medications from a daily dose of three ...

13 sierpnia 2018

10041

In the United States approved a new type of female contraceptive

In the United States approved a new type of female contraceptive

The US Food and Drug Administration (FDA) last Friday, August 10, approved the use of the innovative female contraceptive Annovera (a combination of estrogen and segesterone acetate). The contraceptive is an intravaginal ring that can be used by women throughout the year. ...

10 sierpnia 2018

5458

Supercomputer modeling opens the door for developing new methods of HIV treatment, scientists

Supercomputer modeling opens the door for developing new methods of HIV treatment, scientists

In the middle of last week Nature published the results of a study that established that the naturally occurring compound inositol hexakisphosphate (IP6), involved in both assembly and maturation of HIV-1, could be the key to developing new methods of treating the virus.

1 sierpnia 2018

6259

The results of DolPHIN-1 are summarized: dolutegravir is better than efavirenz cures HIV in women at the extreme stages of pregnancy

The results of DolPHIN-1 are summarized: dolutegravir is better than efavirenz cures HIV in women at the extreme stages of pregnancy

#Dolutegravir demonstrated greater efficacy in suppressing HIV than efavirenz in late pregnancy, Dr. Saye Hu said at the 22nd International AIDS Conference (AIDS2018). According to him, the results of the DolPHIN-1 study showed that in pregnant women of HIV-positive women ...

31 lipca 2018

9283

Doravirin suppresses HIV more effectively than the combination of darunavir / ritonavir

Doravirin suppresses HIV more effectively than the combination of darunavir / ritonavir

An experimental non-nucleoside reverse transcriptase inhibitor (NNRTI), Doravirin, showed greater efficacy in suppressing the viral load of HIV than that of darunavir / ritonavir. These are the results of clinical studies of the 3 phases obtained after 96 weeks of observation ...

30 lipca 2018

8173

WHO has issued updated recommendations for the treatment of hepatitis C

WHO has issued updated recommendations for the treatment of hepatitis C

As the Coalition for Preparedness for Treatment (ITPCru) reported last week, in the end of July, on the eve of World Hepatitis Day, which was held this Saturday, the World Health Organization (WHO) prepared updated recommendations for the treatment of chronic hepatitis C.

1...33 34 35 36 37...117